EFPIA and IFPMA Code Compliance Strategies Richard BERGSTRÖM Chair, EFPIA Code Steering Committee Chair, IFPMA Code Compliance Network Presentation at.

Slides:



Advertisements
Similar presentations
PwC Medical Device Compliance Survey Discussion of Survey Results.
Advertisements

EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Developing the future agenda for STEP What are the key issues for you and your branch?
European Union of Medical Specialists November 18, 2011 Conference John McLoughlin Chairman, European Medical Technology Industry Association (EUCOMED)
Spanish Code of Practice for the Promotion of Medicines CONFIDENTIAL "International congresses, including booth materials and panels, controls related.
Meeting with IESBA CPAB Update Glenn Fagan and Kam Grewal April 7, 2014.
SFEE Disclosure Code October Interactions between the pharmaceutical industry and health care professionals have a profound and positive influence.
Access to Medicine Index 3 rd International Conference for Improving the Use of Medicines Poster 599 Tuesday 15 th November 2011.
Slide 1 Russian Corporate Governance Roundtable meeting Moscow, 11 November 2004 ENFORCEMENT OF IFRS IN the EU Hans van Damme – Vice President FEE FEE.
ADVANCING HEALTHCARE THROUGH INNOVATIVE TECHNOLOGIES AND DEVICES ASSURER DE MEILLEURS SOINS DE SANTÉ GRÂCE À DES TECHNOLOGIES ET DES DISPOSITIFS.
Internal Auditing and Outsourcing
1 Collaborative working in action – an employee perspective Adrian Fricker RMT Lead TU H&S Representative Des More TSSA Lead TU H&S Representative.
Introductory training Medical Technology Industry Code of Practice.
The Ethical Fundraising and Financial Accountability Code.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
THE FRENCH NATIONAL CANCER INSTITUTE (INCa) Focusing care on patients The patient Committee.
New ABPI Code of Practice What are the key messages in the new Code? What difference will the new code make? PDIG 8 th June 2006 Martin Anderson ABPI Director.
URUGUAY National Committee for the Information Society UNCTAD Expert Meeting Electronic Commerce Strategies for Development Geneva 10 – 12 July 2002 Uruguay.
Federal Trade Commission Cross-Border Codes of Conduct Forum Joseph N. Mariano President, United States Direct Selling Association Chairman, World Federation.
Registrant Engagement Through CPD Aoife Sweeney, Head of Education, CORU - Health and Social Care Professionals Council, Ireland.
SMC Horizon Scanning Anne Lee, Scottish Medicines Consortium Julia Earnshaw, GlaxoSmithKline.
Serving the Public. Regulating the Profession.. A Strategic Plan is not an ends… …but rather a means 2.
Implementation of EU Electronic Communication Directives.
A major step towards a Europe for Health Directive on patients’ rights in cross-border healthcare DG SANCO D2 Healthcare Systems.
Revise Lecture 1 1. Framework of Financial Reporting 1. The regulatory system 2. A conceptual framework 2.
Experiences and lessons learned from essential use nominations in Article 2 Parties: European Community perspective Dr. Philippe Tulkens European Commission,
The New EU Directives Oftel Forum 25/04/02 Heather Clayton.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
IOM HACA ‘ Because your health matters’ 30 th April 2012 Andrew Jessopp IOM Health & Care Association.
MERTON LOCAL INVOLVEMENT NETWORK MEETING 27 March 2008 Richard Poxton Centre for Public Scrutiny National Team.
NHS engagement with the EU NHS Confederation Conference 23 June 2010.
HOPE The European Hospital and Healthcare Federation.
Codes of Conduct The International Pharmaceutical Regulatory & Compliance Congress and Best Practice Forum 6 June 2007 Heather Simmonds Director Prescription.
2009/10/06 STUDY ON RECOGNITION OF PROFESSIONAL QUALIFICATIONS Alternative title slide.
April 1, 2010 Lobbying: The Scarlet “L” or Democracy in Action?
Coordination between National Regulators for the Safety and Security of International Shipments of Radioactive Materials between Member States Stephen.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
Setting the Scene: The Role of Ethics and Compliance in the Biopharmaceutical Market.
COCIR Code of Conduct Nicole DENJOY COCIR Secretary General.
Responsible Care® Basic Awareness 1. DISCUSSION POINTS 2 WHAT IS RESPONSIBLE CARE®? HOW DOES RESPONSIBLE CARE® ADD VALUE? WHAT CAN YOU DO TO SUPPORT RESPONSIBLE.
Corporate slide master With guidelines for corporate presentations Integrating Clinical Audit In Policy and Performance Systems
Session 1.01 US Healthcare Professionals Abroad – Issues and Practical Solutions Caroline West – Senior VP, Chief Compliance and Risk Officer Shire Pharmaceuticals.
ROPES & GRAY LLP The Compliance Environment and Grant Process: Oversight and Response in the Pharmaceutical Industry Howard L. Dorfman December 9, 2008.
Sixth Annual Pharmaceutical Compliance Congress and Best Practices Forum International Regulatory & Compliance Issues: Managing Global Compliance Activities.
Setting and Maintaining Standards of Behaviour David Fishel, Positive Solutions
1 October 11, 2006 National Device Audioconference: AdvaMed Code: Better Practices Survey and New Initiatives Steps that AdvaMed is Taking to Promote Compliance.
Building A Pharmaceutical Compliance Program Presentation to the Sixth Annual Congress on Health Care Compliance February 7, 2003 Janice Toran Fujisawa.
Japan Fair Competition Code for Medical Devices Industry (JFCC-MDI)
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
1 Prevention of corruption in the private sector: the view from the Anti-Fraud Office of Catalonia Reducing corruption: focusing on private sector corruption.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
Transparency of payments to healthcare professionals: ABPI plans for a central platform for individual disclosures 2016 June 2014.
IPSF & APPS. What is IPSF? IPSF = International Pharmaceutical Students’ Federation ”IPSF is the leading international advocacy organisation for pharmacy.
Peter Baumgartner, FIAS Transfer Pricing Flagship Event, 13 November 2012 Transfer Pricing in Developing Countries Priorities and concerns of foreign investors.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 31 – Common Foreign and Security Policy.
Medical Device Compliance Congress: Global Device Codes Roundtable - Australia Anne Trimmer.
The IFPMA Code and how to set up a national self-regulation system Presentation to China/EU Pharmaceutical Industry Forum 17 May 2017, Shanghai, China.
The IVD Australia Code of Conduct Edition 2.1
HIMSS Standards Activities
Disclosure UK Talking about Transparency.
Broader Public Sector Expenses Directives and TBRHSC Compliance
REPARIS Workshop Vienna
Disclosure UK Talking about Transparency.
Research for all Sharing good practice in research management
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Industry Induction Course
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

EFPIA and IFPMA Code Compliance Strategies Richard BERGSTRÖM Chair, EFPIA Code Steering Committee Chair, IFPMA Code Compliance Network Presentation at Regulatory and Compliance Congress and Best Practices Forum, Paris, May 2008

Background Top priority during Vasella´s IFPMA Presidency New EFPIA President (Arthur Higgins, Bayer Schering): « Trust is our licence to operate » Renewed attention by WHO Issue with compliance world-wide (CEE, SE Asia, MEA, Central and Latin America...) EU focus on post-marketing studies and support to patient organisations Debate on influence on doctors (CME, medical journals...)

New IFPMA Code New Code with global reach In line with updated Codes in regulated markets Focus on interactions with health care professionals Commitment to prevention Revamped Complaint Procedure Publicity of breaches: « Name and shame » Code and complaint information readily accessible through internet

Main features of new IFPMA Code Restrictive rules on international events (Art 7.1) and company sponsorship (Art 7.2) - travel only allowed for logistical (majority from abroad) or security reasons - spouses not allowed Restrictive rules regarding hospitality provision by companies, including provisions largely restricting entertainment (Art 7.5) - specific amounts for meals - extravagant venues to be avoided - ban on self-standing social activities New provisions defining the extent to which gifts may be offered to healthcare professionals (Art 7.6) - cash never allowed - cultural courtesy gifts to be clearly defined (occasions and values)

IFPMA Code Compliance Network To exchange best practices in code compliance and implementation; To facilitate prevention of breaches by encouraging communication and networking among companies and associations officers; To create a forum for positive communication around industry self-regulation activities; To create a resource pool of experts in code compliance for needs of the IFPMA complaints procedure To stimulate discussions about new challenges related to industry’s promotion and marketing practices

New IFPMA Complaint Procedure IFPMA procedure directly applicable in countries where there are no Codes. Complaints sent to IFPMA in Geneva –Step 1 – the complaint is sent to CEO of the company in alleged breach, with request for clarification; results are communicated to the complainant. –Step 2 – where the company disputes allegation, IFPMA will rule on the case. Director General with 3 members of the Code Compliance Network make a decision. –Step 3 – appeal procedure in case of further dispute; final decision is made by 5 members of the Code Compliance Network. All decisions are made public on the website and summarized in an annual report

New (2007) EFPIA Code Latest national implementation date: July 1, 2008 New chapters on –Non-interventional studies –Consultants –Grants and donations vs. fees for service Separate rules on sponsorship of patient organisations Covers 3rd party contractors Unlike the IFPMA Code, rules on foreign travel and Events (incl. ban on social activities) cover all meetings with HCPs (incl. clinical trial meetings, advisory boards…) EFPIA Code Steering Committee to provide guidance on interpretation

Challenges Not all countries covered Not all sectors covered Need all stakeholders aligned - working with WMA and FIP Congress organisers and medical associations key to success

On the horizon (I)

On the horizon (II)

The only way Accountability and transparency